US Patent 10077264 Derivatives and methods of treating hepatitis B infections
Patent 10077264 was granted and assigned to Novira Therapeutics on September, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10077264 Derivatives and methods of treating hepatitis B infections
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.